Reported Aug 9, 2017 · Terminated
Potassium Phosphates Inj., USP, 45 mM (3 mM P/mL) Also contains: 66 mEq K+ (4.4 mEq/mL) 15 mL, Single-dose, Caution:…
Hospira a Pfizer Company
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Hospira a Pfizer Company · 4285 N Wesleyan Blvd · Rocky Mount, NC · 27804-8612
Is this the product you have?
- Potassium Phosphates Inj., USP, 45
- mM (3 mM P/mL) Also contains66 mEq K+ (4.4 mEq/mL) 15 mL, Single-dose
- CautionMust Be Diluted, Rx Only, Mfd by Hospira, Inc. Lake Forest, IL 60045 USA
- NDC0409-7295-01
- Lot codes and dates
- Lot74119EV Exp. 02/01/2019
- Lot74120EV Exp. 02/01/2019
- Lot74121EV Exp. 02/01/2019
- Lot74307EV Exp. 02/01/2019
- Lot75326EV Exp. 03/01/2019
- Lot75327EV Exp. 03/01/2019
- Lot75215EV Exp. 03/01/2019
- Amount recalled
- 20,337,650 15 mL single dose vials
This recall covers 4 products
The agency filed one notice per product. You are reading one of them; the other 3 are below.
Where it was sold
Why it was recalled
Lack of Sterility Assurance
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Hospira a Pfizer Company recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.